CN114391511B - 一种dss诱导炎症性肠病易患性动物模型的造模方法 - Google Patents
一种dss诱导炎症性肠病易患性动物模型的造模方法 Download PDFInfo
- Publication number
- CN114391511B CN114391511B CN202111606158.XA CN202111606158A CN114391511B CN 114391511 B CN114391511 B CN 114391511B CN 202111606158 A CN202111606158 A CN 202111606158A CN 114391511 B CN114391511 B CN 114391511B
- Authority
- CN
- China
- Prior art keywords
- parts
- inflammatory bowel
- animal model
- bowel disease
- mice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title claims abstract description 59
- 238000010171 animal model Methods 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 27
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 title abstract 3
- 241000699670 Mus sp. Species 0.000 claims abstract description 67
- 235000008085 high protein diet Nutrition 0.000 claims abstract description 27
- 239000003651 drinking water Substances 0.000 claims abstract description 11
- 235000020188 drinking water Nutrition 0.000 claims abstract description 11
- 230000006651 lactation Effects 0.000 claims abstract description 9
- 230000035935 pregnancy Effects 0.000 claims abstract description 9
- 235000020256 human milk Nutrition 0.000 claims abstract description 3
- 210000004251 human milk Anatomy 0.000 claims abstract description 3
- 238000000465 moulding Methods 0.000 claims abstract description 3
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 229960004793 sucrose Drugs 0.000 claims description 6
- 238000011740 C57BL/6 mouse Methods 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 4
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 4
- 235000019393 L-cystine Nutrition 0.000 claims description 4
- 239000004158 L-cystine Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 239000008120 corn starch Substances 0.000 claims description 4
- 229960003067 cystine Drugs 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000004250 tert-Butylhydroquinone Substances 0.000 claims description 4
- 235000019281 tert-butylhydroquinone Nutrition 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 108010076119 Caseins Proteins 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 229940001941 soy protein Drugs 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 229920003045 dextran sodium sulfate Polymers 0.000 claims 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 4
- 229960000633 dextran sulfate Drugs 0.000 claims 4
- 239000011734 sodium Substances 0.000 claims 4
- 229910052708 sodium Inorganic materials 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 1
- 230000010196 hermaphroditism Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 abstract description 17
- 235000005911 diet Nutrition 0.000 abstract description 14
- 238000011160 research Methods 0.000 abstract description 8
- 230000008859 change Effects 0.000 abstract description 7
- 230000007246 mechanism Effects 0.000 abstract description 7
- 230000000378 dietary effect Effects 0.000 abstract description 6
- 230000009471 action Effects 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 238000010276 construction Methods 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 208000027866 inflammatory disease Diseases 0.000 abstract description 2
- 230000003993 interaction Effects 0.000 abstract description 2
- 230000001575 pathological effect Effects 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 210000001072 colon Anatomy 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 235000021590 normal diet Nutrition 0.000 description 10
- 230000037213 diet Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 235000009200 high fat diet Nutrition 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 4
- 206010009887 colitis Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008774 maternal effect Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 206010009900 Colitis ulcerative Diseases 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 208000011231 Crohn disease Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 201000006704 Ulcerative Colitis Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000013165 Bowen disease Diseases 0.000 description 2
- 208000019337 Bowen disease of the skin Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001991 pathophysiological effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000015689 E-Selectin Human genes 0.000 description 1
- 108010024212 E-Selectin Proteins 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
- 101100518501 Mus musculus Spp1 gene Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000033289 adaptive immune response Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000020931 dietary conditions Nutrition 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000035611 feeding Effects 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/25—Animals on a special diet
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0368—Animal model for inflammation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111606158.XA CN114391511B (zh) | 2021-12-25 | 2021-12-25 | 一种dss诱导炎症性肠病易患性动物模型的造模方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111606158.XA CN114391511B (zh) | 2021-12-25 | 2021-12-25 | 一种dss诱导炎症性肠病易患性动物模型的造模方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114391511A CN114391511A (zh) | 2022-04-26 |
CN114391511B true CN114391511B (zh) | 2022-09-23 |
Family
ID=81227240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111606158.XA Active CN114391511B (zh) | 2021-12-25 | 2021-12-25 | 一种dss诱导炎症性肠病易患性动物模型的造模方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114391511B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115053864B (zh) * | 2022-06-24 | 2024-06-18 | 内蒙古大学 | 一种构建绵羊肠炎动物模型的方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101878033A (zh) * | 2007-11-13 | 2010-11-03 | 生物科技医药公司 | 治疗或预防肠道炎症性疾病的方法 |
CN111700906A (zh) * | 2020-05-20 | 2020-09-25 | 山东第一医科大学(山东省医学科学院) | 氢分子的应用及其缓解炎症性肠病小鼠模型的构建方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080260753A1 (en) * | 2004-04-09 | 2008-10-23 | The Regents Of The University Of California | Mouse Models of Crohn's Disease and a Method to Develop Specific Therapeutics |
WO2016186972A1 (en) * | 2015-05-15 | 2016-11-24 | Cedars-Sinai Medical Center | Models, methods and compositions for treating inflammatory bowel disease |
CN112690367A (zh) * | 2020-12-29 | 2021-04-23 | 北京航空航天大学 | 两种不同营养素来源的高脂高蛋白饲料配方及其应用 |
-
2021
- 2021-12-25 CN CN202111606158.XA patent/CN114391511B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101878033A (zh) * | 2007-11-13 | 2010-11-03 | 生物科技医药公司 | 治疗或预防肠道炎症性疾病的方法 |
CN111700906A (zh) * | 2020-05-20 | 2020-09-25 | 山东第一医科大学(山东省医学科学院) | 氢分子的应用及其缓解炎症性肠病小鼠模型的构建方法 |
Non-Patent Citations (3)
Title |
---|
《Maternal High Fat Diet Alters Gut》;Runxiang Xie等;《Frontiers in Immunology》;20181113;第9卷;全文 * |
《Maternal High-Fat Diet Consumption Enhances Offspring》;Shima Bibi等;《Obesity》;20170324;第25卷(第5期);第901-908页 * |
母体甲基供体缺乏对子代小鼠结肠炎发生影响的研究;张蕊等;《世界华人消化杂志》;20171108(第31期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN114391511A (zh) | 2022-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Solà-Oriol et al. | Feeding strategies in pig production: Sows and their piglets | |
Hartmann et al. | Lactogenesis and the effects of insulin-dependent diabetes mellitus and prematurity | |
Rasmussen et al. | Bovine colostrum improves neonatal growth, digestive function, and gut immunity relative to donor human milk and infant formula in preterm pigs | |
Sangild et al. | Invited review: the preterm pig as a model in pediatric gastroenterology | |
Shang et al. | Impact of sugar beet pulp and wheat bran on serum biochemical profile, inflammatory responses and gut microbiota in sows during late gestation and lactation | |
CN112823667B (zh) | 组合物在预防或缓解婴幼儿肠绞痛中的应用 | |
Zebeli et al. | Intermittent parenteral administration of endotoxin triggers metabolic and immunological alterations typically associated with displaced abomasum and retained placenta in periparturient dairy cows | |
CN114391511B (zh) | 一种dss诱导炎症性肠病易患性动物模型的造模方法 | |
Tian et al. | Insulin-like growth factor I reduces the occurrence of necrotizing enterocolitis by reducing inflammatory response and protecting intestinal mucosal barrier in neonatal rats model. | |
Yang et al. | Dietary β-carotene on postpartum uterine recovery in mice: crosstalk between gut microbiota and inflammation | |
KR20120061836A (ko) | 알레르기 예방 및 치료용 프로바이오틱 유래의 비-생육가능성 물질 | |
Castro et al. | Changes in the intestinal bacterial community, short-chain fatty acid profile, and intestinal development of preweaned Holstein calves. 1. Effects of prebiotic supplementation depend on site and age | |
CN112841317A (zh) | 一种适用于高龄产妇喂养的婴幼儿的营养组合物 | |
Pascual et al. | Effect of dietary energy source on the performance and perirenal fat thickness evolution of primiparous rabbit does | |
Chang et al. | Supplementation with galacto-oligosaccharides in early life persistently facilitates the microbial colonization of the rumen and promotes growth of preweaning Holstein dairy calves | |
Jones et al. | Amelioration of the periparturient relaxation of immunity to parasites through a reduction in mammalian reproductive effort | |
Sun et al. | Effect of Saccharomyces cerevisiae boulardii on sows’ farrowing duration and reproductive performance, and weanling piglets’ performance and IgG concentration | |
Shi et al. | Effects of dietary soybean lecithin oil on the immunoglobulin level and fat globule size of milk in lactating sows | |
Suttle et al. | Experimental copper deficiency in sheep | |
Shang et al. | Maternal supplementation with a combination of wheat bran and sugar beet pulp during late gestation and lactation improves growth and intestinal functions in piglets | |
Bohorquez | Nutritional influences on the ultra-structural development of the small intestinal epithelium of the perinatal turkey embryo and poult | |
Liu et al. | Maternal diets have effects on intestinal mucosal flora and susceptibility to colitis of offspring mice during early life | |
WO2021204256A1 (zh) | 乳脂球膜在制备孕妇奶粉中的应用 | |
CN114698732B (zh) | 一种通过调控肠道菌群以改善母体胰岛素抵抗和胎盘发育的日粮纤维 | |
Oyedele et al. | Haematological, biochemical and histological characteristics of broiler chickens fed graded levels of dry distilled cassava with soluble |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Linlin Inventor after: He Suyu Inventor after: Zhou Yuanyuan Inventor after: Liu Tianyu Inventor after: Wang Xiquan Inventor after: Liu Qian Inventor after: Chen Ying Inventor before: Chen Linlin Inventor before: He Suyu Inventor before: Wang Xiquan Inventor before: Liu Tianyu Inventor before: Zhou Yuanyuan Inventor before: Liu Qian Inventor before: Chen Ying |
|
GR01 | Patent grant | ||
GR01 | Patent grant |